Anzeige
Novara — A Smarter Way to Access Global Markets
Markets-Desk·im Tagesverlauf aktualisiert

Aktien

Wall Street Opens Lower as Oil Surge Weighs; Nasdaq Edges Up on AI Stocks
AktienArtikel

Wall Street Opens Lower as Oil Surge Weighs; Nasdaq Edges Up on AI Stocks

Dow fell ~1% to 52,885 and S&P 500 dropped 0.4% to 7,690 on rising oil prices ahead of an ECB rate move; Nasdaq 100 gained 0.1% to 29,578 as AI-related shares offset weakness.

Marktredaktion · 14 Sept 2026
DAX Flat as Oil Hits $100; Fresenius, Kion Lead Gains
AktienArtikel

DAX Flat as Oil Hits $100; Fresenius, Kion Lead Gains

The DAX stalled near 26,007 as Brent approached $100 a barrel on Middle East supply fears. Fresenius and Kion led gains while Infineon fell 4% on a Morgan Stanley downgrade.

Marktredaktion · 14 Sept 2026
Best-Performing Dividend ETFs Over the Past Decade: US and Swiss Comparisons
AktienArtikel

Best-Performing Dividend ETFs Over the Past Decade: US and Swiss Comparisons

YCharts ranks three US dividend ETFs among the top performers of the past decade, while Swiss-listed funds from UBS and BlackRock offer lower-cost alternatives with concentrated SMI exposure.

Marktredaktion · 14 Sept 2026
European Stocks Close Mixed; Novartis Slump Drag on Swiss SMI
AktienArtikel

European Stocks Close Mixed; Novartis Slump Drag on Swiss SMI

The EuroStoxx 50 edged higher while the Swiss SMI fell 1.55% weighed down by Novartis, as investors waited on the ECB rate decision and Brent crude neared $100 a barrel.

Marktredaktion · 14 Sept 2026
European stocks little changed ahead of ECB and US inflation data
AktienArtikel

European stocks little changed ahead of ECB and US inflation data

EuroStoxx 50 rose 0.17% to 6,403.99 as investors awaited Thursday's ECB decision and Friday's US inflation print, while oil shares gained on Gulf tensions.

Marktredaktion · 14 Sept 2026
SMI closes at session low as Novartis posts biggest daily loss ever
AktienArtikel

SMI closes at session low as Novartis posts biggest daily loss ever

The Swiss benchmark fell 1.55% to 14,047, dragged by Novartis (-10.9%) after a Phase III study failure. UBS rose to a 19-year high above 45 francs.

Marktredaktion · 14 Sept 2026
US stocks fall as oil nears $100; Novartis posts steep loss
AktienArtikel

US stocks fall as oil nears $100; Novartis posts steep loss

US indices slipped on higher oil prices and rate-hike concerns, while Novartis fell 9.8% after another trial disappointment and the SMI stayed near its low.

Marktredaktion · 14 Sept 2026
Novartis plunges as oil and rate worries push US and Swiss stocks lower
AktienArtikel

Novartis plunges as oil and rate worries push US and Swiss stocks lower

Novartis fell more than 9% after a phase-III miss, dragging the SMI lower as US stocks slipped on rising oil prices and rate-hike expectations.

Marktredaktion · 14 Sept 2026
US Markets Slide as Oil Hits $98; Novartis Plunges Toward Record Loss
AktienArtikel

US Markets Slide as Oil Hits $98; Novartis Plunges Toward Record Loss

Brent crude climbs toward $100 on Middle East tensions, weighing on Wall Street and Switzerland's SMI. Novartis falls nearly 10% after Phase III trial miss, wiping out roughly CHF 24 billion in market value.

Marktredaktion · 14 Sept 2026
US Markets Mixed After Holiday; Oil Weighs on Sentiment as Novartis Plunges
AktienArtikel

US Markets Mixed After Holiday; Oil Weighs on Sentiment as Novartis Plunges

Dow futures sink 0.8% as Brent crude approaches $100; Novartis shares tumble over 9% after second clinical miss hits Swiss index.

Marktredaktion · 14 Sept 2026
Dax slips as Brent crude nears $100 and oil prices pressure German stocks
AktienArtikel

Dax slips as Brent crude nears $100 and oil prices pressure German stocks

The Dax fell to 25,975 in early afternoon trade as Brent crude approached $100 and WTI and European gas prices rose, while stock-specific ratings drove moves in Dax and MDax names.

Marktredaktion · 13 Sept 2026
US Stocks Expected to Open Mixed After Holiday; Oil Prices Pressuring Sentiment; SMI Continues Decline; Novartis Targets Record Daily Loss
AktienArtikel

US Stocks Expected to Open Mixed After Holiday; Oil Prices Pressuring Sentiment; SMI Continues Decline; Novartis Targets Record Daily Loss

US stock indices show slight movements before market open; oil prices rise, fueling concerns over rising interest rates; Swiss Market Index (SMI) continues to fall; Novartis shares plunge, potentially setting a record daily loss.

Marktredaktion · 13 Sept 2026
Novartis trial miss drags Swiss SMI lower; Nestlé, Ascom gain
AktienArtikel

Novartis trial miss drags Swiss SMI lower; Nestlé, Ascom gain

Novartis shares fell nearly 10% after Del-desiran missed a Phase III endpoint, pulling the SMI lower while Nestlé, Sandoz and Ascom gained and Brent approached $100.

Marktredaktion · 13 Sept 2026
European stocks flat; Novartis plunge weighs on Switzerland's SMI
AktienArtikel

European stocks flat; Novartis plunge weighs on Switzerland's SMI

Markets held steady as high energy prices and inflation fears kept investors cautious, while a failed drug trial sent Novartis shares tumbling nearly 9%, dragging the Swiss SMI down more than 1%.

Marktredaktion · 13 Sept 2026
European Stocks Stay Flat; Novartis Study Flop Weighs on Swiss SMI
AktienArtikel

European Stocks Stay Flat; Novartis Study Flop Weighs on Swiss SMI

EuroStoxx 50 flat as high oil and gas prices persist. The Swiss SMI drops 1.18% while Novartis shares fall over 9% after a failed drug trial sinks the stock.

Marktredaktion · 13 Sept 2026
Novartis Plunges After Failed Muscle-Disease Trial; SMI Slides 1.3%
AktienArtikel

Novartis Plunges After Failed Muscle-Disease Trial; SMI Slides 1.3%

Novartis tumbled nearly 10% after its del-desiran candidate missed a Phase III primary endpoint, erasing roughly CHF 24 billion in market value and pulling the SMI lower. Nestlé and Roche helped stem the damage.

Marktredaktion · 13 Sept 2026
Swiss SMI opens lower as Novartis slides over 10% on trial setbacks; Nestlé leads gains
AktienArtikel

Swiss SMI opens lower as Novartis slides over 10% on trial setbacks; Nestlé leads gains

Novartis shares fell more than 10% to CHF 112.54 after missing primary endpoints in two late‑stage studies, dragging the SMI down 1.4%. Nestlé rose 2% while copper hit a record $14,533 a tonne.

Marktredaktion · 13 Sept 2026
Swiss Re shares drop 3.6% after Monte Carlo risk warning
AktienArtikel

Swiss Re shares drop 3.6% after Monte Carlo risk warning

The insurer fell to CHF 137.70 on Monday following comments at the industry’s Rendez‑Vous de Septembre meeting about rising reinsurance risks, while dividend yield remains at 4.4%.

Marktredaktion · 13 Sept 2026
European chip stocks rise on AI demand as Infineon gets Warburg buy
AktienArtikel

European chip stocks rise on AI demand as Infineon gets Warburg buy

Infineon rose nearly 7% after Warburg upgraded it to Buy with a 84-euro target, while UBS lifted memory-chip revenue forecasts to $1.65 trillion by 2027.

Marktredaktion · 13 Sept 2026
European stocks little changed ahead of ECB decision and US inflation data
AktienArtikel

European stocks little changed ahead of ECB decision and US inflation data

European equities were little moved Monday as investors awaited the ECB decision and US inflation data; oil shares rose on Gulf tensions while the SMI fell on Novartis and Swiss Re.

Marktredaktion · 13 Sept 2026
DAX slips 0.15% to 26,006 as Brent holds above $97, ECB rate hike expected
AktienArtikel

DAX slips 0.15% to 26,006 as Brent holds above $97, ECB rate hike expected

Germany's blue‑chip index fell 0.15% to 26,006.53 points, staying just above the 26,000 threshold, while Brent crude traded above $97 per barrel and markets price an ECB rate rise to 2.5%.

Marktredaktion · 13 Sept 2026
SMI falls 0.8% as Novartis and Swiss Re lead losses
AktienArtikel

SMI falls 0.8% as Novartis and Swiss Re lead losses

Switzerland's benchmark index closed at 14,279 after Novartis and Swiss Re weighed, while ABB, Kühne+Nagel and semiconductor suppliers offset some declines.

Marktredaktion · 13 Sept 2026
Mirabaud sees Swiss equities as global niche leaders, not just defensive
AktienArtikel

Mirabaud sees Swiss equities as global niche leaders, not just defensive

Daniele Scilingo sees Swiss stocks as global niche leaders, warns AI valuations are stretched, and points to compounders, China adaptation, pharma innovation and UBS.

Marktredaktion · 13 Sept 2026
EuroStoxx 50 slides 0.8% as oil price rise fuels inflation fears
AktienArtikel

EuroStoxx 50 slides 0.8% as oil price rise fuels inflation fears

The Euro Stoxx 50 fell to 6,368.98, its lowest since early August, as higher oil prices and heightened Iran tensions revived inflation concerns and expectations of an ECB rate hike. Swiss and UK indices also moved modestly.

Marktredaktion · 13 Sept 2026